Pfizer opens review for global Lipitor account
NEW YORK: Pfizer has put its global Lipitor account up for review, two and a half years after it awarded the business to a consortium of WPP firms, led by Cohn & Wolfe and Burson-Marsteller.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>